Lupus Nephritis
📧 Sign up to get email alerts when something new happens for Lupus Nephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-05-14Clinical Trial Update: Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis [NA]
A open-label pilot trial of rituximab for lupus membranous nephritis has been withdrawn.
-
CLINICAL_TRIALS research · 2015-05-06Clinical Trial Update: The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear
A clinical trial update examining the synergistic effects of mycophenolic acid and lipopolysaccharide on IL-1β secretion by mononuclear cell…
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: Functional MRI in Lupus Nephritis
This update notes a completed clinical trial evaluating functional MRI in lupus nephritis sponsored by Biogen.
-
CLINICAL_TRIALS withdrawal · 2015-02-27Clinical Trial Update: Clinical Trial Treatment in Lupus Nephritis [Phase 3]
A Phase 3 clinical trial in lupus nephritis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients [Phase 3]
A Phase 3 study comparing tacrolimus capsules with leflunomide tablets in lupus nephritis patients was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis [Phase 3]
Phase 3 trial evaluating enteric-coated mycophenolate sodium (Myfortic) for relapse or resistant proliferative lupus nephritis was terminate…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis [Phase 2]
Phase 2 clinical trial evaluating the combination of abatacept and cyclophosphamide for lupus nephritis completed with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis. [Phase 3]
Phase 3 trial of CellCept (mycophenolate mofetil) for lupus nephritis was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis [Phase 1]
Amgen's Phase 1 safety study of AMG 811 in subjects with systemic lupus erythematosus, with and without lupus nephritis, has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-17Clinical Trial Update: A Study to Evaluate Efficacy of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis [Phase 3]
A Phase 3 study evaluating the efficacy of CellCept (mycophenolate mofetil) in lupus nephritis was terminated, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis [Phase 4]
This Phase 4 trial update compares tacrolimus versus mycophenolate mofetil as initial therapy for active lupus nephritis, reporting on effic…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis [Phase 4]
Phase 4 clinical trial update evaluating a low-dose combination of mycophenolate mofetil and tacrolimus for refractory lupus nephritis.
-
CLINICAL_TRIALS withdrawal · 2014-02-12Clinical Trial Update: Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis [Phase 3]
A Phase 3 trial evaluating tacrolimus sustained-release capsules for induction therapy in lupus nephritis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
This update reports the baseline characteristics of participants enrolled in a Lupus Nephritis biomarker study (NCT01470183). The study stat…
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis [Phase 3]
This Phase 3 trial comparing mycophenolate mofetil to tacrolimus for membranous lupus nephritis has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-22Clinical Trial Update: Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil [Phase 1]
Phase 1 trial of atacicept in lupus nephritis patients on stable mycophenolate mofetil has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis [Phase 3]
Phase 3 trial update on concentration-controlled therapy with mycophenolate mofetil for proliferative lupus nephritis; the study status is c…
-
FDA approval · 2013-09-27FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Sandoz Inc's mycophenolate mofetil.
-
FDA approval · 2013-09-27FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for MYCOPHENOLATE MOFETIL by Accord Healthcare Inc., marking an update to its regulatory status rela…
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis [NA]
A completed clinical trial evaluated the efficacy and safety of a multi-target therapy for lupus nephritis.
-
CLINICAL_TRIALS research · 2013-05-29Clinical Trial Update: The Effect of Calcitriol on Progress and Activity of Lupus Nephritis [Phase 2]
Phase 2 clinical trial investigating calcitriol for progression and activity in lupus nephritis associated with systemic lupus erythematosus…
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis [Phase 4]
Phase 4 clinical trial update indicating completion of a study evaluating long-acting tacrolimus for resistant lupus nephritis.
-
FDA approval · 2012-09-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for mycophenolate mofetil, the generic immunosuppressant, via Teva Pharmaceuticals USA, Inc. This ac…
-
FDA approval · 2012-09-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for mycophenolate mofetil submitted by Mylan Pharmaceuticals Inc. The action updates the product's l…
-
FDA approval · 2012-09-25FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Mycophenolate mofetil from Strides Pharma Science Limited, enabling the generic product to b…